Dr Rishi Desai (Boston, USA) and Dr Marwan Bukhari discuss the risk of venous thromboembolism associated with tofacitinib in rheumatoid arthritis. Dr Desai’s recent paper used claims data to compare the risk of VTE with tofacitinib vs. TNFis. 

Read the paper here

Thanks for listening to Talking Rheumatology Research! Join the conversation on X using #TalkingRheumResearch, tweet us @RheumJnl, or find us on Instagram and LinkedIn.

Want to read more rheumatology research? Explore Rheumatology and Rheumatology Advances in Practice.